Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

From Acid Reflux to Health Hazard: The Growing Cancer Threat Associated with Ranitidine

View through CrossRef
Ranitidine is a medication used for heart burn, stomach ulcer, gastroesophageal reflux disorder and other conditions that cause an accumulation of stomach acid. The side/adverse effects of ranitidine use include CNS disturbance such as dizziness and vomiting, nausea. Other reported side effects include cholestatic hepatitis, hematologic disorders such as leucopenia, and granulocytopenia, respiratory effects, and musculoskeletal complications. It is an H2 histamine blocker drug. Recently some studies have found that ranitidine may containthe presence of potentially carcinogenic compounds such as N-Nitrosodimethylamine. The purpose of this study was to assess the relationship between ranitidine consumption and gastrointestinal cancer. Proton pump inhibitor (PPI) ana H2 antagonistrelated events that were reported to the FDA Adverse Events Reporting System were chosen. To compare the percentage of all reported adverse events that were for gastrointestinal system malignancies among ranitidine adverse event reports to adverse event reports for other H2 antagonists, proportionate reporting ratios (PRRs) and related 95% confidence intervals were calculated.Compared to PPIs and other H2 antagonists, ranitidine had a higher percentage of adverse events for any gastrointestinal system malignancy relative to all other events (PRR 3.66, 95% Ci 3.19-4.20). Cancers of the pharynx (PRR 9.24), esophagus (PRR 3.56), stomach (PRR 1.48), colorectal (PRR 16.31), liver (PRR 2.64), and pancreas(PRR 2.18) all had elevated and substantial PRRs. Although not statistically significant, the PRRs for gallbladder (PRR 4.62) and anal (PRR 4.62) cancer were likewise higher. This discovery is raising concerns about drug related diseases long-term consumption of ranitidine may increase the risk of cancerseveral health authorities have launched an investigation and recommended its removal from the market. To make consumer aware in the context and it is necessary to guide towards safe option.
Title: From Acid Reflux to Health Hazard: The Growing Cancer Threat Associated with Ranitidine
Description:
Ranitidine is a medication used for heart burn, stomach ulcer, gastroesophageal reflux disorder and other conditions that cause an accumulation of stomach acid.
The side/adverse effects of ranitidine use include CNS disturbance such as dizziness and vomiting, nausea.
Other reported side effects include cholestatic hepatitis, hematologic disorders such as leucopenia, and granulocytopenia, respiratory effects, and musculoskeletal complications.
It is an H2 histamine blocker drug.
Recently some studies have found that ranitidine may containthe presence of potentially carcinogenic compounds such as N-Nitrosodimethylamine.
The purpose of this study was to assess the relationship between ranitidine consumption and gastrointestinal cancer.
Proton pump inhibitor (PPI) ana H2 antagonistrelated events that were reported to the FDA Adverse Events Reporting System were chosen.
To compare the percentage of all reported adverse events that were for gastrointestinal system malignancies among ranitidine adverse event reports to adverse event reports for other H2 antagonists, proportionate reporting ratios (PRRs) and related 95% confidence intervals were calculated.
Compared to PPIs and other H2 antagonists, ranitidine had a higher percentage of adverse events for any gastrointestinal system malignancy relative to all other events (PRR 3.
66, 95% Ci 3.
19-4.
20).
Cancers of the pharynx (PRR 9.
24), esophagus (PRR 3.
56), stomach (PRR 1.
48), colorectal (PRR 16.
31), liver (PRR 2.
64), and pancreas(PRR 2.
18) all had elevated and substantial PRRs.
Although not statistically significant, the PRRs for gallbladder (PRR 4.
62) and anal (PRR 4.
62) cancer were likewise higher.
This discovery is raising concerns about drug related diseases long-term consumption of ranitidine may increase the risk of cancerseveral health authorities have launched an investigation and recommended its removal from the market.
To make consumer aware in the context and it is necessary to guide towards safe option.

Related Results

Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Background. The drugs that are often given to children with GERD are stomach acidsuppressants, namely the H2 receptor antagonist and proton pump inhibitor (PPI) classof drugs, but ...
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan
Polypharmacy may be considered as the customary practice to provide optimum care services to patients but inter resulted in augmented probability of multiple drug interaction. Keep...
Pendekatan Diagnostik Refluks Laring Faring
Pendekatan Diagnostik Refluks Laring Faring
Abstract: Lifestyle and behavior changes can have bad impacts on our health. One of the diseases that can be caused by lifestyle changes is pharyngeal larynx reflux. Pharyngeal lar...
SYNERGISTIC DRUG-DRUG INTERACTION;
SYNERGISTIC DRUG-DRUG INTERACTION;
Introduction: Ranitidine is known to us all as an anti-ulcer drug which acts byblocking H2 receptors in the stomach parietal cells. However its role in this category has beenunders...
The role of psychological distress in laryngopharyngeal reflux patients: a prospective questionnaire study
The role of psychological distress in laryngopharyngeal reflux patients: a prospective questionnaire study
Clin. Otolaryngol. 2010, 35, 25–30.Objectives:  To determine the role of psychological distress in laryngopharyngeal reflux patients and evaluate the correlation between symptoms, ...
Prevalence of Esophagitis in Patients With pH‐Documented Laryngopharyngeal Reflux
Prevalence of Esophagitis in Patients With pH‐Documented Laryngopharyngeal Reflux
AbstractObjective To report the prevalence of esophagitis in patients with pH‐documented laryngopharyngeal reflux.Study Design Prospective study of 58 consecutive patients with doc...

Back to Top